Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 2
1964 5
1965 4
1966 5
1967 4
1968 2
1969 2
1970 2
1971 8
1972 1
1973 4
1974 5
1975 11
1976 2
1977 7
1978 2
1979 1
1980 2
1981 5
1982 5
1983 2
1984 1
1985 2
1986 5
1987 2
1988 4
1989 4
1990 3
1991 2
1992 3
1993 6
1994 6
1995 7
1996 11
1997 5
1998 3
1999 12
2000 17
2001 17
2002 17
2003 35
2004 22
2005 22
2006 15
2007 23
2008 22
2009 23
2010 18
2011 33
2012 48
2013 44
2014 66
2015 58
2016 44
2017 49
2018 49
2019 50
2020 57
2021 53
2022 26
Text availability
Article attribute
Article type
Publication date

Search Results

843 results
Results by year
Filters applied: . Clear all
Page 1
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Neuen BL, Oshima M, Agarwal R, Arnott C, Cherney DZ, Edwards R, Langkilde AM, Mahaffey KW, McGuire DK, Neal B, Perkovic V, Pong A, Sabatine MS, Raz I, Toyama T, Wanner C, Wheeler DC, Wiviott SD, Zinman B, Heerspink HJL. Neuen BL, et al. Among authors: toyama t. Circulation. 2022 May 10;145(19):1460-1470. doi: 10.1161/CIRCULATIONAHA.121.057736. Epub 2022 Apr 8. Circulation. 2022. PMID: 35394821 Free article.
[Alcohol dependence].
Toyama T, Matsushita S. Toyama T, et al. Nihon Rinsho. 2013 Oct;71(10):1837-41. Nihon Rinsho. 2013. PMID: 24261216 Japanese.
[Ⅲ.Estrogen Receptor and MicroRNA].
Toyama T, Wanifuchi-Endo Y. Toyama T, et al. Gan To Kagaku Ryoho. 2019 Dec;46(12):1844-1847. Gan To Kagaku Ryoho. 2019. PMID: 31879401 Japanese. No abstract available.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Saji S, Taira N, Kitada M, Takano T, Takada M, Ohtake T, Toyama T, Kikawa Y, Hasegawa Y, Fujisawa T, Kashiwaba M, Ishida T, Nakamura R, Yamamoto Y, Toh U, Iwata H, Masuda N, Morita S, Ohno S, Toi M. Saji S, et al. Among authors: toyama t. Lancet Oncol. 2022 May;23(5):636-649. doi: 10.1016/S1470-2045(22)00196-6. Epub 2022 Apr 8. Lancet Oncol. 2022. PMID: 35405087 Clinical Trial.
843 results